What does Enavate Sciences invest in?
Enavate Sciences invests most often at Series C (100% of the rounds on record), in sectors such as Celle Therapy, Pharmaceuticals and Drug.

United States · Investor
Last cheque observed May 2024. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
1 rounds on record
Mostly Series C: 100% of its rounds
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companiesFrom their own website
Every round we can evidence, newest first1 appearances
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies Enavate Sciences put money into.
Enavate Sciences invests most often at Series C (100% of the rounds on record), in sectors such as Celle Therapy, Pharmaceuticals and Drug.
1 investments on record, 0 of them in the last 12 months. The most recent was in May 2024.
Its most recent investments on record: Zenas BioPharma (Series C, May 2024).
The median round it joins is $200M.
No investments in the last 12 months; the latest was in May 2024.
Enavate Sciences is a VC firm based in New York, United States.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it